Roweepra is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Owp Pharmaceuticals, Inc.. The primary component is Levetiracetam.
| Product ID | 69102-108_68f61297-c3f6-4adf-b2b1-edfeb5b006c0 |
| NDC | 69102-108 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Roweepra |
| Generic Name | Levetiracetam |
| Dosage Form | Tablet |
| Route of Administration | ORAL |
| Marketing Start Date | 2020-10-28 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA078858 |
| Labeler Name | OWP Pharmaceuticals, Inc. |
| Substance Name | LEVETIRACETAM |
| Active Ingredient Strength | 250 mg/1 |
| Pharm Classes | Decreased Central Nervous System Disorganized Electrical Activity [PE] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2021-12-31 |
| Marketing Start Date | 2020-10-28 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 69102-102 | ROWEEPRA | ROWEEPRA |
| 69102-104 | ROWEEPRA | ROWEEPRA |
| 69102-103 | ROWEEPRA | ROWEEPRA |
| 69102-101 | ROWEEPRA | ROWEEPRA |
| 69102-108 | Roweepra | Roweepra |
| 0054-0224 | Levetiracetam | Levetiracetam |
| 0121-0799 | Levetiracetam | LEVETIRACETAM |
| 0121-1598 | Levetiracetam | LEVETIRACETAM |
| 0121-2397 | Levetiracetam | LEVETIRACETAM |
| 0121-4799 | Levetiracetam | LEVETIRACETAM |
| 0121-4802 | LEVETIRACETAM | LEVETIRACETAM |
| 0143-9574 | Levetiracetam | Levetiracetam |
| 0143-9673 | Levetiracetam | Levetiracetam |
| 0228-2167 | Levetiracetam | Levetiracetam |
| 0378-5613 | Levetiracetam | levetiracetam |
| 0378-5615 | Levetiracetam | levetiracetam |
| 0378-5617 | Levetiracetam | levetiracetam |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() ROWEEPRA 86634147 5209905 Live/Registered |
OWP Pharmaceuticals, Inc. 2015-05-19 |